<p>To date different techniques of platelet concentrates (PC) preparation and processing are proposed to achieve the best efficiency of transfusions and to minimize the risks post-transfusion reactions. However, data on the impact of different approaches to PC preparation and processing on morphological and functional characteristics of platelets and, as a consequence, the clinical efficacy of transfusions is controversial. In this paper we analyzed the impact of the platelet storage solution and different methods of pathogen inactivation (X-rays, UV-irradiation after photosensitization with riboflavin) on morphological and functional parameters of platelets. Our findings allow optimizing the technology of preparation and processing of PC t...
Since 1990, several techniques have been developed to photochemically inactivate pathogens in platel...
Background/Case Studies: New platelet additive solutions (PAS) containcompounds that might improve t...
Transfusions of platelet concentrates (PCs) are given to maintain primary hemostasis in patients wit...
textabstractBackground: A photochemical treatment (PCT) process for inactivation of infectious patho...
Platelets are specialized cellular elements of the blood that play central roles in physiologic and ...
The characterization of platelet concentrates (PCs) in transfusion medicine has been performed with ...
Background : Recent studies suggested that platelets can be activated during the preparation of plat...
Background: Transfusion of platelet concentrates (PCs) is the basic treatment for severe platelet di...
AbstractSince 1990, several techniques have been developed to photochemically inactivate pathogens i...
Background and Objectives: Since 2015, platelet products have been pathogen-inactivated (PI) at the ...
Storage of platelet concentrates (PCs) has an impact on platelet quality and possibly affects their ...
Background/Case Studies: In the past decade, technology for inactivation of potential pathogens and ...
Pathogen reduction technologies are implemented to increase the safety of blood products. We previou...
This thesis includes various studies on improving the collection and preservation of the platelet pr...
textabstractA nucleic acid-targeted photochemical treatment (PCT) using amotosalen HCl (S-59) and ul...
Since 1990, several techniques have been developed to photochemically inactivate pathogens in platel...
Background/Case Studies: New platelet additive solutions (PAS) containcompounds that might improve t...
Transfusions of platelet concentrates (PCs) are given to maintain primary hemostasis in patients wit...
textabstractBackground: A photochemical treatment (PCT) process for inactivation of infectious patho...
Platelets are specialized cellular elements of the blood that play central roles in physiologic and ...
The characterization of platelet concentrates (PCs) in transfusion medicine has been performed with ...
Background : Recent studies suggested that platelets can be activated during the preparation of plat...
Background: Transfusion of platelet concentrates (PCs) is the basic treatment for severe platelet di...
AbstractSince 1990, several techniques have been developed to photochemically inactivate pathogens i...
Background and Objectives: Since 2015, platelet products have been pathogen-inactivated (PI) at the ...
Storage of platelet concentrates (PCs) has an impact on platelet quality and possibly affects their ...
Background/Case Studies: In the past decade, technology for inactivation of potential pathogens and ...
Pathogen reduction technologies are implemented to increase the safety of blood products. We previou...
This thesis includes various studies on improving the collection and preservation of the platelet pr...
textabstractA nucleic acid-targeted photochemical treatment (PCT) using amotosalen HCl (S-59) and ul...
Since 1990, several techniques have been developed to photochemically inactivate pathogens in platel...
Background/Case Studies: New platelet additive solutions (PAS) containcompounds that might improve t...
Transfusions of platelet concentrates (PCs) are given to maintain primary hemostasis in patients wit...